CDC7 inhibitors

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CDC7 KINASE INHIBITORS AND USES THEREOF
EP 4201402 A1申请人: SLOAN KETTERING INST CANCER RES优先权: 2010
EP
US
16 件公开
METHODS OF TREATMENT OF CANCER COMPRISING CDC7 INHIBITORS
- EP 3856352 A4
  申请人: SIERRA ONCOLOGY INC优先权: 2018
  CN
  EP
  US
  WO
  6 件公开
- WO 2019165473 A1
  申请人: SIERRA ONCOLOGY INC优先权: 2018
  WO
HETEROCYCLIC PERICONDENSED CDC7 KINASE INHIBITORS FOR THE TREATMENT OF CANCER
EP 4211140 A1申请人: SCHROEDINGER INC优先权: 2020
CN
EP
US
WO
5 件公开
Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7
US 8314121 B2申请人: LEROY VINCENT优先权: 2006
CN
US
3 件公开
Screen for CDC7 inhibitors
US 6953672 B2申请人: MILLENNIUM PHARM INC优先权: 2002
US
3 件公开
INDAZOLE COMPOUNDS AND METHODS FOR INHIBITION OF CDC7
US 2007293491 A1申请人: NOVARTIS VACCINES & DIAGNOSTIC优先权: 2006
CN
US
2 件公开
COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS
US 2024207300 A1申请人: REPARE THERAPEUTICS INC优先权: 2021
CN
US
2 件公开
Thienopyrimidine as CDC7 kinase inhibitors
US 8691828 B2申请人: OGURO YUYA优先权: 2010
US
2 件公开
CDC7 inhibitors
US 9156824 B2申请人: LILLY CO ELI优先权: 2014
US
2 件公开
SUBSTITUTED [5,6]CYCLIC-4(3H)-PYRIMIDINONES AS ANTICANCER AGENTS
CN 112409373 A申请人: NANJING ZHENGJI MEDICINE RES CO LTD优先权: 2017
CN